Synthesis of a versatile mitochondria-targeting small molecule for cancer near-infrared fluorescent imaging and radio/photodynamic/photothermal synergistic therapies
Source abstract
Abstract
Although as a mainstay modal for cancer treatment, the clinical effect of radiotherapy (RT) does not yet meet the need of cancer patients. Developing tumour-preferential radiosensitizers or combining RT with other treatments has been acknowledged highly necessary to enhance the efficacy of RT. The present study reported a multifunctional bioactive small-molecule (designated as IR-83) simultaneously exhibiting tumour-preferential accumulation, near-infrared imaging and radio/photodynamic/photothermal therapeutic effects. IR-83 was designed and synthesized by introducing 2-nitroimidazole as a radiosensitizer into the framework of heptamethine cyanine dyes inherently with tumour-targeting and photosensitizing effects. As results, IR-83 preferentially accumulated in tumours, suppressed tumour growth and metastasis by integrating radio/photodynamic/photothermal multimodal therapies. Mechanism studies showed that IR-83 accumulated in cancer cell mitochondria, induced excessive reactive oxygen species (ROS), and generated high heat after laser irradiation. On one hand, these phenomena led to mitochondrial dysfunction and a sharp decline in oxidative phosphorylation to lessen tissue oxygen consumption. On the other hand, excessive ROS in mitochondria destroyed the balance of antioxidants and oxidative stress balance by down-regulating the intracellular antioxidant system, and subsequently sensitized ionizing radiation-generated irreversible DNA double-strand breaks. Therefore, this study presented a promising radiosensitizer and a new alternative strategy to enhance RT efficacy via mitochondria-targeting multimodal synergistic treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Cancer, Stress, Anesthesia, and Immune Response
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. The integration of radiotherapy with immunotherapy for the treatment of non-small cell lung cancer10.1158/1078-0432.CCR-17-3620 ↗
2. Ionizing radiation-induced DNA damage, response, and repair10.1089/ars.2013.5668 ↗
3. Unrepairable DNA double-strand breaks that are generated by ionising radiation determine the fate of normal human cells
4. The impact of hypoxia and its modification of the outcome of radiotherapy10.1093/jrr/rrw007 ↗
5. Mitochondrion-anchoring photosensitizer with aggregation-induced emission characteristics synergistically boosts the radiosensitivity of cancer cells to ionizing radiation10.1002/adma.201606167 ↗
6. Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy10.1038/s41467-018-06655-7 ↗
7. New combination treatment from ROS-Induced sensitized radiotherapy with nanophototherapeutics to fully eradicate orthotopic breast cancer and inhibit metastasis10.1016/j.biomaterials.2020.120229 ↗
8. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
9. Chen · 2021
10. Radioiodinated persistent luminescence nanoplatform for radiation-induced photodynamic therapy and radiotherapy
11. Photosensitizer-functionalized nanocomposites for light-activated cancer theranostics10.3390/ijms22136658 ↗
12. Photothermal therapy10.1016/j.jconrel.2020.06.032 ↗
13. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy10.1021/nl100996u ↗
14. The effect of hyperthermia on vascular function, pH, and cell survival10.1148/radiology.137.3.7444064 ↗
15. Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy10.1016/j.addr.2020.07.007 ↗
16. Tissue physiology and the response to heat10.1080/02656730600689066 ↗
17. Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis10.1016/j.ijrobp.2015.12.361 ↗
18. Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses10.1080/02656736.2016.1195924 ↗
19. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy10.1039/C9TB02248A ↗
20. Synthesis of BSA-coated BiOI@Bi(2) S(3) semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor10.1002/adma.201704136 ↗
21. Multifunctional nanotheranostic gold nanocages for photoacoustic imaging guided radio/photodynamic/photothermal synergistic therapy10.1016/j.actbio.2018.11.043 ↗
22. Cancer therapy improvement with mesoporous silica nanoparticles combining photodynamic and photothermal therapy10.1088/0957-4484/25/28/285701 ↗
23. Photodynamic therapy of cancer: an update
24. Roadmap to clinical use of gold nanoparticles for radiation sensitization10.1016/j.ijrobp.2015.09.032 ↗
25. A multifunctional heptamethine near-infrared dye for cancer theranosis10.1016/j.biomaterials.2012.11.057 ↗
26. A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties10.1016/j.biomaterials.2011.11.081 ↗
27. Mitochondria-targeted small-molecule fluorophores for dual modal cancer phototherapy10.1002/adfm.201600159 ↗
28. Structure-guided design and synthesis of a mitochondria-targeting near-infrared fluorophore with multimodal therapeutic activities10.1002/adma.201704196 ↗
29. Synthesis of mitochondria-anchored nitroimidazoles with a versatile NIR fluorophore for hypoxic tumor-targeting imaging and chemoradiotherapy10.1021/acs.jmedchem.0c02250 ↗
30. Cooperation of ESIPT and ICT processes in the designed 2-(2'-hydroxyphenyl)benzothiazole derivative: a near-infrared two-photon fluorescent probe with a large Stokes shift for the detection of cysteine and its application in biological environments10.1021/acs.analchem.0c03490 ↗
31. A novel multifunctional 2-nitroimidazole-based bioreductive linker and its application in hypoxia-activated prodrugs10.1016/j.bioorg.2020.103975 ↗
32. Photo-based PDT/PTT dual model killing and imaging of cancer cells using phycocyanin-polypyrrole nanoparticles10.1016/j.ejpb.2017.11.007 ↗
33. Thiol-capped Bi nanoparticles as stable and all-in-one type theranostic nanoagents for tumor imaging and thermoradiotherapy10.1016/j.biomaterials.2018.01.047 ↗
34. Copper selenide nanocrystals for photothermal therapy10.1021/nl201400z ↗
35. Hydrophilic Cu9S5 nanocrystals: a photothermal agent with a 25.7% heat conversion efficiency for photothermal ablation of cancer cells in vivo10.1021/nn203293t ↗
36. Mitochondria-targeting magnetic composite nanoparticles for enhanced phototherapy of cancer10.1002/smll.201601094 ↗
37. Enhanced radiotherapy using bismuth sulfide nanoagents combined with photo-thermal treatment10.7150/thno.20548 ↗
38. Tumor radioresponsiveness versus fractionation sensitivity10.1016/0360-3016(86)90081-7 ↗
39. Phase II trial of a simultaneous radiochemotherapy with cisplatinum and paclitaxel in combination with hyperfractionated-accelerated radiotherapy in locally advanced head and neck tumors10.1385/MO:23:3:325 ↗
40. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy10.1016/j.biomaterials.2012.05.047 ↗
41. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication10.1016/j.molcel.2008.05.016 ↗
42. A near-infrared triggered nanophotosensitizer inducing domino effect on mitochondrial reactive oxygen species burst for cancer therapy10.1021/acsnano.5b04501 ↗
43. Mito-bomb: targeting mitochondria for cancer therapy
44. Targetable fluorescent probe for monitoring exogenous and endogenous NO in mitochondria of living cells10.1021/ac401916z ↗
45. Mitochondrial dynamics and its involvement in disease10.1146/annurev-pathmechdis-012419-032711 ↗
46. Mitochondrial network structure homeostasis and cell death10.1111/cas.13830 ↗
47. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy10.1038/sj.emboj.7601963 ↗
48. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry10.1038/cddis.2012.171 ↗
49. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement10.1016/j.redox.2020.101674 ↗
50. Metabolic heterogeneity in human lung tumors10.1016/j.cell.2015.12.034 ↗
51. Tumors and mitochondrial respiration: a neglected connection10.1158/0008-5472.CAN-15-0491 ↗
52. Mitochondria targeting as an effective strategy for cancer therapy10.3390/ijms21093363 ↗
53. Identification of ROS using oxidized DCFDA and flow-cytometry10.1007/978-1-60761-411-1_4 ↗
54. A mitochondria-targeted nanoradiosensitizer activating reactive oxygen species burst for enhanced radiation therapy10.1039/C7SC04458E ↗
55. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis10.1038/nature10189 ↗
56. Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria10.1016/j.taap.2018.09.014 ↗
57. A perspective on cancer cell metastasis10.1126/science.1203543 ↗
58. Hypoxia-dependent angiogenesis and lymphangiogenesis in cancer10.1007/978-3-030-12734-3_5 ↗
59. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy10.1016/S0304-3835(96)04528-4 ↗
60. Derivation of endothelial cells from CD34- umbilical cord blood10.1634/stemcells.22-3-385 ↗
61. HIF-1α pathway: role, regulation and intervention for cancer therapy10.1016/j.apsb.2015.05.007 ↗
62. Isobologram analysis: a comprehensive review of methodology and current research10.3389/fphar.2019.01222 ↗
63. Paul Ehrlich's magic bullet concept: 100 years of progress10.1038/nrc2394 ↗